SGCA
CVS icon

Steel Grove Capital Advisors’s CVS Health CVS Stock Holding History

Steel Grove Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,872
Closed -$213K – 199
2023
Q1 		$213K Hold
2,872
– – 0.03% 171
2022
Q4 		$268K Hold
2,872
– – 0.04% 140
2022
Q3 		$274K Buy
2,872
+77
+3% +$7.62K 0.05% 120
2022
Q2 		$259K Hold
2,795
– – 0.05% 124
2022
Q1 		$283K Hold
2,795
– – 0.04% 127
2021
Q4 		$288K Hold
2,795
– – 0.06% 122
2021
Q3 		$237K Buy
+2,795
New +$234K 0.05% 125
2019
Q1 		– Sell
-6,030
Closed -$395K – 155
2018
Q4 		$395K Sell
6,030
-366
-6% -$27.3K 0.06% 220
2018
Q3 		$503K Buy
6,396
+464
+8% +$33.2K 0.07% 202
2018
Q2 		$382K Sell
5,932
-79
-1% -$5.21K 0.06% 222
2018
Q1 		$374K Sell
6,011
-5,408
-47% -$388K 0.06% 237
2017
Q4 		$828K Buy
11,419
+15
+0.1% +$1.09K 0.12% 149
2017
Q3 		$927K Sell
11,404
-3,123
-21% -$247K 0.17% 113
2017
Q2 		$1.17M Sell
14,527
-4,451
-23% -$351K 0.21% 95
2017
Q1 		$1.49M Sell
18,978
-618
-3% -$49.3K 0.26% 79
2016
Q4 		$1.55M Buy
19,596
+9,948
+103% +$805K 0.31% 74
2016
Q3 		$859K Buy
9,648
+1,106
+13% +$104K 0.19% 83
2016
Q2 		$818K Buy
8,542
+13
+0.2% +$1.3K 0.2% 81
2016
Q1 		$885K Sell
8,529
-986
-10% -$95.9K 0.22% 77
2015
Q4 		$930K Sell
9,515
-2
-0% -$196 0.23% 89
2015
Q3 		$918K Buy
9,517
+1,930
+25% +$203K 0.23% 78
2015
Q2 		$796K Buy
7,587
+2,188
+41% +$224K 0.18% 82
2015
Q1 		$557K Buy
+5,399
New +$546K 0.13% 87
2014
Q3 		$480K Buy
6,030
+14
+0.2% +$1.1K 0.11% 87
2014
Q2 		$453K Buy
6,016
+16
+0.3% +$1.21K 0.11% 84
2014
Q1 		$449K Buy
6,000
+16
+0.3% +$1.13K 0.11% 92
2013
Q4 		$428K Buy
5,984
+15
+0.3% +$964 0.11% 94
2013
Q3 		$339K Buy
5,969
+15
+0.3% +$894 0.1% 97
2013
Q2 		$340K Buy
+5,954
New +$345K 0.11% 94

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Steel Grove Capital Advisors's CVS Position: Q2 2023 in Review

Steel Grove Capital Advisors sold out of CVS Health (CVS) in Q2 2023, closing a stake of 2,872 shares — an estimated $213K sold.

Steel Grove Capital Advisors first reported a position in CVS in Q2 2013 and held it in 29 quarters. The position peaked at $1.55M in Q4 2016. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Steel Grove Capital Advisors reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Steel Grove Capital Advisors sold 2,872 CVS Health shares in Q2 2023, an estimated $213K.
  • Steel Grove Capital Advisors first reported a position in CVS Health in Q2 2013 and held it in 29 quarters.
  • Steel Grove Capital Advisors's CVS Health position peaked at $1.55M in Q4 2016.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Steel Grove Capital Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.